You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucagon

Showing 1 - 25 of 2,606
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Fat and Glucagon Resistance

Not yet recruiting
  • Steatosis of Liver
  • Acute glucagon infusion
  • (no location specified)
Nov 22, 2023

Type 1 Diabetes Trial in Trondheim (Glucagon)

Recruiting
  • Type 1 Diabetes
  • Glucagon
  • Trondheim, Norway
    Department of Endocrinology, St. Olavs Hospital
Jul 17, 2023

Obesity Trial in Orlando (Glucagon)

Active, not recruiting
  • Obesity
  • Glucagon
  • Orlando, Florida
    Translational Research Institute for Metabolism and Diabetes
Feb 1, 2023

Hypoglycemia and Glucagon Response in CF

Completed
  • Cystic Fibrosis
  • +3 more
    • Istanbul, Turkey
      Marmara University, School of Medicine
    Jan 25, 2023

    Post-bariatric Hypoglycemia Trial in Boston (glucagon, Closed loop glucagon pump)

    Completed
    Has Results
    • Post-bariatric Hypoglycemia
    • glucagon
    • Closed loop glucagon pump
    • Boston, Massachusetts
      Joslin Diabetes Center
    Aug 7, 2022

    Obesity, Type2diabetes, NAFLD Trial in Rochester (Glucagon response study)

    Not yet recruiting
    • Obesity
    • +2 more
    • Glucagon response study
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 11, 2022

    Glucagon-like Peptide-1 Receptor Agonists According to Type 2

    Recruiting
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Bari, Italy
      Azienda Ospedaliero-Universitaria Policlinico Bari
    Nov 4, 2023

    Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

    Not yet recruiting
    • Overweight and Obesity
    • 24-hour ambulatory blood pressure
    • Liberal salt diet
    • (no location specified)
    Oct 4, 2023

    Preoperative Prandial State of Patients Taking Glucagon-Like

    Recruiting
    • Pulmonary Aspiration
    • Gastric ultrasound
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Jun 6, 2023

    Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Glucose Metabolism Disorders Trial in Aarhus (glucagon)

    Completed
    • Non-Alcoholic Fatty Liver Disease
    • +2 more
    • glucagon
    • Aarhus, Danmark, Denmark
      Aarhus University Hospital
    Nov 3, 2022

    Effects of Glucagon-like-Peptide-1 Analogues on Sexuality

    Recruiting
    • Sexual Desire
      • Basel, Switzerland
        University Hospital Basel, Endocrinology, Diabetes and Metabolis
      Nov 28, 2022

      Type 1 Diabetes, Hypoglycemia Trial in Herlev (GlucaGen)

      Recruiting
      • Type 1 Diabetes
      • Hypoglycemia
      • Herlev, Denmark
        Steno Diabetes Center Copenhagen
      Sep 14, 2022

      Stroke, Stroke, Acute, Stroke, Ischemic Trial in Linyi, Hong Kong (Semaglutide)

      Recruiting
      • Stroke
      • +3 more
      • Linyi, Shangdong, China
      • +1 more
      Jun 24, 2023

      Sepsis, Thiamine Deficiency Trial in Medan (Vitamin B, Placebo)

      Completed
      • Sepsis
      • Thiamine Deficiency
      • Vitamin B
      • Placebo
      • Medan, Sumatera Utara, Indonesia
        Faculty of Medicine Universitas Sumatera Utara
      Dec 21, 2022

      Diabetes Insipidus Trial in Basel (Glucagon, Placebo)

      Completed
      • Diabetes Insipidus
      • Glucagon
      • Placebo
      • Basel, Switzerland
        Divison of Endocrinology, Diabetes and Metabolism,University Hos
      May 18, 2022

      Type 1 Diabetes, Hyperglycemia, Postprandial Trial in Saint Louis (Insulin)

      Terminated
      Has Results
      • Type 1 Diabetes
      • Hyperglycemia, Postprandial
      • Saint Louis, Missouri
        Washington University in St Louis
      Sep 13, 2022

      Cardiovascular Diseases Trial in Cambridge (Saline 0.9%, Glucagon (25ng/kg/min), Glucagon (50ng/kg/min))

      Recruiting
      • Cardiovascular Diseases
      • Saline 0.9%
      • +3 more
      • Cambridge, Cambridgeshire, United Kingdom
        Addenbrooke's Hospital
      Dec 10, 2021

      Hyperglycemia Drug Induced Trial in Durham (REMD-477)

      Terminated
      • Hyperglycemia Drug Induced
      • REMD-477
      • Durham, North Carolina
        Duke University Medical Center
      Nov 4, 2022

      Type 1 Diabetes, Hypoglycemia Trial in Bern (Micro-glucagon, Mini-glucagon)

      Not yet recruiting
      • Type 1 Diabetes
      • Hypoglycemia
      • Bern, Switzerland
        Department of Diabetes, Endocrinology, Nutritional Medicine and
      May 19, 2022

      Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

      Not yet recruiting
      • Gastric Ultrasound
      • +2 more
      • Gastric Ultrasound Exam
      • (no location specified)
      Aug 15, 2023

      MODY1, MODY3 Trial in Oxford (Omission of gliclazide)

      Completed
      • MODY1
      • MODY3
      • Omission of gliclazide
      • Oxford, Oxfordshire, United Kingdom
        Clinical Research Unit, OCDEM, Churchill Hospital
      Aug 16, 2022

      Type 2 Diabetes, Obesity Trial in Cambridge (0.9% Sodium-chloride, Exenatide (50ng/min for 30 minutes loading followed by

      Recruiting
      • Type 2 Diabetes
      • Obesity
      • 0.9% Sodium-chloride
      • +3 more
      • Cambridge, Cambridgeshire, United Kingdom
        Cambridge University Hospitals NHS Foundation Trust and The Univ
      Jan 18, 2022

      Type2diabetes Trial in Rochester (Caloric Restriction, Hyperglycemic clamp)

      Not yet recruiting
      • Type2diabetes
      • Caloric Restriction
      • Hyperglycemic clamp
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Aug 11, 2022

      Insulin Sensitivity Trial in San Antonio (Glucagon Infusion, Saline)

      Recruiting
      • Insulin Sensitivity
      • Glucagon Infusion
      • Saline
      • San Antonio, Texas
      • +1 more
      Sep 8, 2022

      Diabetes, Type 1 Trial in Almelo (Dasiglucagon, GlucaGen)

      Not yet recruiting
      • Diabetes Mellitus, Type 1
      • Almelo, Overijssel, Netherlands
        ZGT hospital
      Jul 7, 2022